Published in Kardiol Pol on January 01, 2013
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation (2004) 4.31
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention (2015) 4.00
FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study. J Am Coll Cardiol (2013) 2.87
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J (2009) 2.68
[Apical ballooning syndrome in a 57-year-old woman during premedication for general anaesthesia]. Kardiol Pol (2006) 2.67
Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society. Kardiol Pol (2008) 2.63
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
[Arrythmogenic right ventricular cardiomyopathy in patient with abnormal origin of right coronary artery and ventricular tachycardia during exercises]. Kardiol Pol (2012) 2.45
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res (2008) 2.12
Regional differences in determining cardiovascular diseases as the cause of death in Poland: time for change. Kardiol Pol (2012) 2.06
Long-term follow-up of mesh-covered stent implantation in patients with ST-segment elevation myocardial infarction. Kardiol Pol (2013) 2.04
Is evaluation of complex polymorphism helpful in the assessment of prognosis after percutaneous coronary intervention. A prospective study. Kardiol Pol (2011) 2.03
OSACS score-a new simple tool for identifying high risk for Obstructive Sleep Apnea Syndrome based on clinical parameters. Anatol J Cardiol (2014) 1.99
Prognostic value of renal fractional flow reserve in blood pressure response after renal artery stenting (PREFER study). Cardiol J (2013) 1.98
Coronary computed tomography angiography for the assessment of SYNTAX score. Kardiol Pol (2016) 1.97
Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis--a case report and review of the literature. Int J Cardiol (2005) 1.95
Efficacy of multi-electrode duty-cycled radiofrequency ablation in patients with paroxysmal and persistent atrial fibrillation. Cardiol J (2013) 1.93
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90
The role of cardiac registries in evidence-based medicine. Eur Heart J (2010) 1.83
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J (2013) 1.77
Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2005) 1.71
2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) (2015) 1.69
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes. JACC Cardiovasc Interv (2010) 1.67
Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest (2007) 1.66
Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol (2009) 1.65
Prevalence and characteristics of coronary anomalies originating from the opposite sinus of Valsalva in 8,522 patients referred for coronary computed tomography angiography. Am J Cardiol (2013) 1.64
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. Eur Heart J (2004) 1.58
Influence of C3435T multidrug resistance gene-1 (MDR-1) polymorphism on platelet reactivity and prognosis in patients with acute coronary syndromes. Kardiol Pol (2009) 1.54
The size does not matter - the presence of microvascular obstruction but not its extent corresponds to larger infarct size in reperfused STEMI. Eur J Radiol (2011) 1.51
Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. Cardiovasc Revasc Med (2012) 1.48
Leptin in acute myocardial infarction and period of convalescence in patients with type 2 diabetes mellitus. Kardiol Pol (2010) 1.47
Transcatheter aortic valve implantation using transfemoral/transsubclavian or transapical approach: 30-day follow-up of the initial 30 patients. Kardiol Pol (2011) 1.46
Cognitive disorders in elderly patients with permanent atrial fibrillation. Kardiol Pol (2009) 1.46
Availability of automated external defibrillators in the city of Warsaw - status for May 2009. Kardiol Pol (2010) 1.45
Desmin expression in human cardiomyocytes and selected clinical and echocardiographic parameters in patients with chronic heart failure. Kardiol Pol (2009) 1.45
Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetes mellitus. Kardiol Pol (2011) 1.44
Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomized trial. J Thorac Cardiovasc Surg (2012) 1.44
Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - clinical outcome and 1-year follow-up. Cardiology (2013) 1.44
Efficacy of catheter ablation in patients with an electrical storm. Kardiol Pol (2011) 1.43
Comparison of on-admission ST-segment elevation tako-tsubo patients and myocardial infarction women: in-hospital course and long-term follow-up. Kardiol Pol (2012) 1.43
The ROX coupler: creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature. Catheter Cardiovasc Interv (2014) 1.43
Virtual histology intravascular ultrasound evaluation of the left anterior descending coronary artery in patients with transient left ventricular ballooning syndrome. Kardiol Pol (2010) 1.43
The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation. Kardiol Pol (2009) 1.42
What has changed in the treatment of ST-segment elevation myocardial infarction in Poland in 2003-2009? Data from the Polish Registry of Acute Coronary Syndromes (PL-ACS). Kardiol Pol (2011) 1.42
CHA2DS2-VASc and R2CHA2DS2-VASc scores have predictive value in patients with acute coronary syndromes. Pol Arch Med Wewn (2015) 1.41
Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function? Kardiol Pol (2011) 1.41
Early implementation of continuous venovenous haemodiafiltration improves outcome in patients with heart failure complicated by acute kidney injury. Kardiol Pol (2011) 1.41
Access to selected diagnostic procedures in the management of heart failure patients in Poland - POLKARD 2005. Kardiol Pol (2010) 1.41
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results. Kardiol Pol (2012) 1.41
Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality. Eur Heart J (2009) 1.41
Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries. Kardiol Pol (2012) 1.41
Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis. Catheter Cardiovasc Interv (2011) 1.41
Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study. Cardiol J (2009) 1.41
IgG, IgM and inflammatory markers serum concentration in patients with acute coronary syndrome: a pilot study. Kardiol Pol (2012) 1.41
No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.41
Abrasions of the outer silicone insulation of endocardial leads in their intracardiac part: a new mechanism of lead-dependent endocarditis. Europace (2012) 1.40
Functionally driven complete vs incomplete revascularisation in multivessel coronary artery disease--long-term results from a large cohort. Kardiol Pol (2010) 1.40
Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting. Kardiol Pol (2009) 1.40
Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation. Int J Cardiol (2002) 1.40
Predictors of infarct-related artery patency following combined lytic therapy in patients with ST-segment elevation myocardial infarction treated with immediate percutaneous coronary intervention. Kardiol Pol (2011) 1.40
Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure. Kardiol Pol (2009) 1.40
Primary percutaneous angioplasty, thrombolysis and conservative treatment in low-risk patients with ST-elevation myocardial infarction: effects on short- and long-term mortality. Kardiol Pol (2012) 1.39
Can thromboembolic risk be associated with erectile dysfunction in atrial fibrillation patients? Cardiol J (2015) 1.39
[Report from China Interventional Therapeutics 2008, Beijing, China 19-23.03.2008]. Kardiol Pol (2008) 1.39
'Syringe-in-the-pocket'--a new approach to the outpatient thromboembolic prophylaxis of recurrent atrial fibrillation. Cardiology (2007) 1.39
[Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience]. Kardiol Pol (2012) 1.39
Age-related gap in the management of heart failure patients. The National Project of Prevention and Treatment of Cardiovascular Diseases--POLKARD. Cardiol J (2012) 1.39
Plasma adiponectin in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol (2010) 1.39
Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Kardiol Pol (2009) 1.39
Transcatheter aortic valve implantation using direct aortic access: first procedures in Poland. Kardiol Pol (2012) 1.39
[Percutaneous treatment of periprosthetic valve leak in patients not suitable for reoperation]. Kardiol Pol (2010) 1.39
Osborn waves during therapeutic hypothermia in a young ST-ACS patient after out-of-hospital cardiac arrest. Kardiol Pol (2013) 1.39
Evaluation of safety and the success rate of cryoballoon ablation of the pulmonary vein ostia in patients with atrial fibrillation--a preliminary report. Kardiol Pol (2010) 1.39
Percutaneous closure of paravalvular leak and ventricular septum defect. Catheter Cardiovasc Interv (2011) 1.39
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res (2015) 1.39
Initial troponin level may predict thrombus burden in patients with acute coronary syndrome. Optical coherence tomography study. Kardiol Pol (2012) 1.38
Cumulative incidence of coronary lesions with vulnerable characteristics in patients with stable angina pectoris: an intravascular ultrasound and angiographic study. Int J Cardiol (2005) 1.38
Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database. Pol Arch Med Wewn (2016) 1.38
Percutaneous dilatation of coarctation of the aorta, stenotic pulmonary arteries or homografts, and stenotic superior vena cava using Andrastents XL and XXL. Kardiol Pol (2011) 1.38
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med (2013) 1.32